MiR-423-5p promotes Müller cell activation via targeting NGF signaling in diabetic retinopathy

Yanqiu Liu1, Zifan Xu1, Haohan Zheng1

  • 1Department of Ophthalmology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, 299 Qingyang Road, Wuxi, Jiangsu 214023, People's Republic of China.

Life Sciences
|November 4, 2023
PubMed
Abstract

Insights

MicroRNA-423-5p promotes diabetic retinopathy (DR) by activating retinal Müller cells and causing microvascular dysfunction. Inhibiting miR-423-5p ameliorates these DR-related changes, highlighting its role in the disease.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Endocrinology

Background:

  • Diabetic retinopathy (DR) is a leading cause of vision loss, characterized by neuro-glial and vascular changes.
  • Müller cell (rMC) activation is an early event in DR pathogenesis.
  • MicroRNAs (miRNAs) are implicated in DR progression.

Purpose of the Study:

  • To investigate the role of miR-423-5p in Müller cell activation.
  • To elucidate the mechanism of miR-423-5p in diabetic retinopathy (DR).

Main Methods:

  • Utilized streptozotocin (STZ)-induced diabetic mice and oxygen-induced retinopathy (OIR) models.
  • Assessed retinal histology, optical coherence tomography (OCT), and biochemical markers.
  • Investigated miRNA-mRNA interactions using 3' UTR luciferase assays.

Main Results:

  • miR-423-5p expression increased in high-glucose conditions.
  • Overexpression of miR-423-5p accelerated vascular leakage, leukocytosis, and rMC activation.
  • miR-423-5p directly silences nerve growth factor (NGF), promoting microvascular dysfunction.

Conclusions:

  • miR-423-5p is a key driver of microvascular dysfunction in diabetic retinopathy (DR).
  • Targeting miR-423-5p may offer a therapeutic strategy for DR.

Related Concept Videos